Eltrombopag — Cigna
Thrombocytopenia in a patient due to immune checkpoint inhibitor therapy
Initial criteria
- Patient has tried at least one systemic corticosteroid
- Patient has a platelet count < 50 x 10^9/L (< 50,000/mcL)
- The medication is prescribed by or in consultation with a hematologist or an oncologist
Reauthorization criteria
- According to the prescriber, the patient demonstrated a beneficial clinical response
Approval duration
6 months